|
Name |
Helminthosporic acid
|
| Molecular Formula | C15H24O3 | |
| IUPAC Name* |
(1R,4R,5S,8S)-8-(hydroxymethyl)-1,7-dimethyl-4-propan-2-ylbicyclo[3.2.1]oct-6-ene-6-carboxylic acid
|
|
| SMILES |
CC1=C([C@H]2[C@H](CC[C@@]1([C@H]2CO)C)C(C)C)C(=O)O
|
|
| InChI |
InChI=1S/C15H24O3/c1-8(2)10-5-6-15(4)9(3)12(14(17)18)13(10)11(15)7-16/h8,10-11,13,16H,5-7H2,1-4H3,(H,17,18)/t10-,11+,13+,15+/m1/s1
|
|
| InChIKey |
RBCVCNVBAWEHLS-MPXAEWJHSA-N
|
|
| Synonyms |
Helminthosporic acid; CHEMBL53386; (1R,4R,5S,8S)-8-(Hydroxymethyl)-1,7-dimethyl-4-propan-2-ylbicyclo[3.2.1]oct-6-ene-6-carboxylic acid
|
|
| CAS | NA | |
| PubChem CID | 14165721 | |
| ChEMBL ID | CHEMBL53386 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 252.35 | ALogp: | 2.7 |
| HBD: | 2 | HBA: | 3 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 57.5 | Aromatic Rings: | 2 |
| Heavy Atoms: | 18 | QED Weighted: | 0.808 |
| Caco-2 Permeability: | -4.663 | MDCK Permeability: | 0.00001070 |
| Pgp-inhibitor: | 0.009 | Pgp-substrate: | 0.04 |
| Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.017 |
| 30% Bioavailability (F30%): | 0.02 |
| Blood-Brain-Barrier Penetration (BBB): | 0.812 | Plasma Protein Binding (PPB): | 93.18% |
| Volume Distribution (VD): | 0.4 | Fu: | 7.85% |
| CYP1A2-inhibitor: | 0.203 | CYP1A2-substrate: | 0.622 |
| CYP2C19-inhibitor: | 0.02 | CYP2C19-substrate: | 0.747 |
| CYP2C9-inhibitor: | 0.059 | CYP2C9-substrate: | 0.212 |
| CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.114 |
| CYP3A4-inhibitor: | 0.043 | CYP3A4-substrate: | 0.475 |
| Clearance (CL): | 3.879 | Half-life (T1/2): | 0.781 |
| hERG Blockers: | 0.041 | Human Hepatotoxicity (H-HT): | 0.224 |
| Drug-inuced Liver Injury (DILI): | 0.874 | AMES Toxicity: | 0.009 |
| Rat Oral Acute Toxicity: | 0.719 | Maximum Recommended Daily Dose: | 0.013 |
| Skin Sensitization: | 0.348 | Carcinogencity: | 0.122 |
| Eye Corrosion: | 0.56 | Eye Irritation: | 0.931 |
| Respiratory Toxicity: | 0.956 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001779 | ![]() |
0.673 | D04CSZ | ![]() |
0.267 | ||
| ENC005679 | ![]() |
0.549 | D01CKY | ![]() |
0.247 | ||
| ENC003555 | ![]() |
0.541 | D04GJN | ![]() |
0.223 | ||
| ENC005686 | ![]() |
0.493 | D02IIW | ![]() |
0.222 | ||
| ENC005680 | ![]() |
0.479 | D0IX6I | ![]() |
0.216 | ||
| ENC003488 | ![]() |
0.460 | D0KR5B | ![]() |
0.216 | ||
| ENC005687 | ![]() |
0.451 | D08PIQ | ![]() |
0.212 | ||
| ENC005678 | ![]() |
0.421 | D0S8LV | ![]() |
0.211 | ||
| ENC005682 | ![]() |
0.398 | D04SFH | ![]() |
0.211 | ||
| ENC004664 | ![]() |
0.382 | D0I2SD | ![]() |
0.211 | ||